Analyze industry leading sales and medical data in a standardized and comparable way, including cross-country analysis of performance and additional insights into global and regional markets.
Gold-Standard Data Meets Agentic AI
IQVIA Global Market Insights (GMI) Agent delivers a unified view of the global market landscape by combining agentic AI and IQVIA's gold standard datasets to answer complex, multi-dimensional questions. It helps you analyze market shifts through real-time HCP sentiment, optimize launch strategies with competitive intelligence, and uncover growth opportunities by tracking trends across sales, promotional channels, and physician engagement.
GMI Agent also provides forward-looking insights with pipeline analysis, loss-of-protection (LoP) timelines, and market forecasts, so you can anticipate change and act with confidence.
Simply ask a question and get comprehensive answers in near real time.
Transform Your Understanding of Global Pharmaceutical Markets
Optimize Insights Across the Product Lifecycle with Agentic AI
Early Development: Evaluate Commercial Potential
- Gain a clear view of the competitive and patent landscape
Map competitors, pipeline progression, and exclusivity timelines to ensure your brand strategy is built on a solid understanding of opportunities, threats and timing constraints. - Quantify where and how big your market opportunities really are
Accurately size and segment the market using forecasted uptake and patient data, so you can focus resources on the most promising geographies and indications. - Prioritize pipeline investments for maximum future value
Select the assets with the greatest potential by integrating pipeline, patient, and forecast data, ensuring your investments align with both market opportunity and competitive realities. - Shape a differentiated brand position based on HCP insights
Understand how healthcare professionals perceive your pipeline assets and identify unique differentiators to inform early positioning and messaging. - Maximize future returns by learning from past channel performance
Use historical channel benchmarks to make smarter early-stage investment and channel selection decisions, setting your future launches up for success.
Pre-Launch: Strategic Market Planning
-
Anticipate competitor moves and market saturation
Map competitor launch timelines and readiness to refine your go-to-market strategy and ensure your brand enters at the right time. - Optimize launch timing and sequencing
Finalize launch order using robust forecasts, so you can capture market share efficiently and effectively. - Protect revenue by managing patent and generic entry risks
Assess exclusivity periods and patent cliffs to maximize protected revenue and proactively adjust pricing and contracting strategies. - Boost launch success by tailoring channel mix and messaging
Optimize your pre-launch plans by identifying which channels and messages will resonate most. - React rapidly to market signals for agile pre-launch strategy
Monitor early market feedback and adjust your approach in real time, leveraging forecast shifts and competitive intelligence to stay ahead.
Launch: Maximize Market Entry
-
Validate and course-correct your launch in real time
Track actual uptake versus forecasts to quickly identify what’s working, enabling rapid adjustments for optimal launch performance. - Defend market share by proactively managing exclusivity windows
Monitor patent status and exclusivity to adapt your strategy if generics or biosimilars enter earlier than expected, protecting your brand’s value - Stay competitive by monitoring rival launches and pipeline progress
Continuously track competitor activity to anticipate market shifts and inform timely defensive or offensive moves. - Drive prescriber engagement with data-driven messaging refinement
Use HCP feedback and intention data to fine-tune your messaging and engagement, maximizing impact on prescribing behavior. - Maximize ROI by dynamically optimizing channel investments
Adjust promotional tactics and channel spend in real time, ensuring every investment delivers the highest possible return throughout the launch phase.
Post Launch: Continuous Optimization
-
Sustain success by continuously tracking performance against plan
Monitor ongoing sales and uptake versus forecasts to spot deviations early and take corrective action before issues escalate. - Minimize brand erosion by managing generic entry proactively
Track generic uptake and adjust promotional and pricing strategies to defend your brand’s position after loss of exclusivity. - Safeguard your brand by anticipating competitive threats
Assess brand health and monitor competitor pipeline activity to stay ahead of potential share erosion or new market entrants. - Unlock new growth by identifying emerging market opportunities
Analyze prescribing trends and uptake data to uncover new areas for investment, leveraging pipeline and forecast insights. - Optimize future investments with predictive resource allocation
Use historical performance and forecast data to continually refine investment decisions across geographies, channels, and segments.
Ask anything. Understand everything.
GMI Agent instantly synthesizes millions of these data points to deliver clear recommendations, competitive insights, and strategic guidance you can act on immediately.
Frequently Asked Questions
GMI Agent accelerates every stage of commercialization through unified intelligence. For pre-launch, it identifies unmet needs, assesses market readiness across 95 countries and provides market forecasts. During launch, it monitors HCP sentiment and promotional effectiveness to optimize messaging and channel mix. Post-launch, it continuously tracks performance, identifies emerging opportunities, and can provide strategic inputs.
By connecting MIDAS sales data, ChannelDynamics promotional insights, ChannelDynamics Verbatim HCP feedback, and Market Prognosis forecasts in one platform, teams get answers in minutes that traditionally take weeks or even months—enabling faster, more confident decisions across product performance, positioning, and market expansion.
- "Which competitors are gaining share in emerging diabetes markets and what messages are resonating the most with HCPs?"
- "How is HCP sentiment about my respiratory portfolio affecting market share trends across EU5?"
- "If we delay Japan launch by 6 months, how will that impact our competitive position and 5-year forecast?"
- "Where are we losing share of voice to competitors and what's the projected impact on market share?"
INDUSTRY ARTICLE
Agenda 2026: Changes brewing in the agency world
Discover market leaders’ perspectives on how expectations of agency partners are shifting for 2026—from the new skills and operating models brand leaders will demand, to broader changes reshaping the agency landscape—and the pharma marketing trends quietly emerging with outsized strategic impact, including digital twins.
Industry Article
From weeks to minutes: How AI transforms pharma market entry strategy
In this Pharmaphorum article, discover how agentic AI transforms market entry decisions from weeks to minutes. Learn how pharmaceutical organizations unify fragmented sales, promotional, and competitive data through natural language queries - delivering real-time strategic insights that accelerate launch success.
Related solutions
Measure the performance of your sales force and marketing channels, adapt your commercial strategy and gain real world competitive insights.
Accelerate strategic decision making with a clear view on future market dynamics, now powered by AI
Strengthen your portfolio by making more informed decisions and prepare for the impact of new research discoveries.
IQVIA Analytics Link Ecosystem establishes deep connections across our key data assets.
Track more than 60,000 pharmaceutical patent families across 130 countries to find opportunities and ensure timely business decisions.
